DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report)’s stock price was up 4.7% on Friday . The stock traded as high as $0.2403 and last traded at $0.2310. Approximately 163,340 shares were traded during trading, an increase of 17% from the average daily volume of 139,720 shares. The stock had previously closed at $0.2206.
DIAGNOS Trading Up 4.7%
The company has a market cap of $27.08 million, a price-to-earnings ratio of -5.78 and a beta of -0.02. The company has a quick ratio of 0.73, a current ratio of 0.39 and a debt-to-equity ratio of 1.23. The company’s 50-day moving average is $0.23 and its 200 day moving average is $0.19.
DIAGNOS (OTCMKTS:DGNOF – Get Free Report) last announced its quarterly earnings results on Thursday, November 20th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.01 million during the quarter.
DIAGNOS Company Profile
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
Featured Stories
- Five stocks we like better than DIAGNOS
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- What is a Secondary Public Offering? What Investors Need to Know
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
